These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 15249239
1. Hormone replacement therapy in postmenopausal women. Staren ED, Omer S. Am J Surg; 2004 Aug; 188(2):136-49. PubMed ID: 15249239 [Abstract] [Full Text] [Related]
2. Menopause and stroke and the effects of hormonal therapy. Lobo RA. Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [Abstract] [Full Text] [Related]
3. A comparative review of the risks and benefits of hormone replacement therapy regimens. Warren MP. Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656 [Abstract] [Full Text] [Related]
4. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E, Canfell K. Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078 [Abstract] [Full Text] [Related]
5. Where are we with postmenopausal hormone therapy in 2005? Lam PM, Chung TK, Haines C. Gynecol Endocrinol; 2005 Nov 01; 21(5):248-56. PubMed ID: 16373243 [Abstract] [Full Text] [Related]
6. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease. Lowe GD. J Intern Med; 2004 Nov 01; 256(5):361-74. PubMed ID: 15485471 [Abstract] [Full Text] [Related]
7. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT)-the University of Florida experience. Levens E, Williams RS. Am J Obstet Gynecol; 2004 Aug 01; 191(2):641-6; discussion 646-7. PubMed ID: 15343254 [Abstract] [Full Text] [Related]
8. Lessons learned from the WHI: HRT requires a cautious and individualized approach. Aubuchon M, Santoro N. Geriatrics; 2004 Nov 01; 59(11):22-6. PubMed ID: 15615157 [Abstract] [Full Text] [Related]
10. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy]. Stjernquist M, North American Menopause Society (NAMS) Advisory Panel. Lakartidningen; 2003 May 15; 100(20):1790-7. PubMed ID: 12806859 [Abstract] [Full Text] [Related]
11. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program. Hillman JJ, Zuckerman IH, Lee E. J Womens Health (Larchmt); 2004 Nov 15; 13(9):986-92. PubMed ID: 15665655 [Abstract] [Full Text] [Related]
12. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts]. Motolese M. Ital Heart J Suppl; 2003 Jul 15; 4(7):545-58. PubMed ID: 14558283 [Abstract] [Full Text] [Related]
13. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Kuhl H, Stevenson J. Gynecol Endocrinol; 2006 Jun 15; 22(6):303-17. PubMed ID: 16785155 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy: what is the evidence today? Uebelhart B, Frey D, Uebelhart D. Z Rheumatol; 2003 Dec 15; 62(6):508-11. PubMed ID: 14685710 [Abstract] [Full Text] [Related]
17. HRT and cardiovascular disease. Stevenson JC. Best Pract Res Clin Obstet Gynaecol; 2009 Feb 15; 23(1):109-20. PubMed ID: 19095500 [Abstract] [Full Text] [Related]
18. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause]. Maas AH, van der Graaf Y. Ned Tijdschr Geneeskd; 2002 Nov 09; 146(45):2127-30. PubMed ID: 12474550 [Abstract] [Full Text] [Related]
19. WHI risks: any relevance to menopause management? Burger HG. Maturitas; 2007 May 20; 57(1):6-10. PubMed ID: 17368974 [Abstract] [Full Text] [Related]
20. Cancer issues. Marsden J, Sturdee D. Best Pract Res Clin Obstet Gynaecol; 2009 Feb 20; 23(1):87-107. PubMed ID: 19036643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]